Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.70 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30405136 | 0.95 | ACHE (0.68) | ACHEEPHX2EPHX1 | |
| SCHEMBL25166871 | 0.93 | ACHE (0.71) | ACHEEPHX2EPHX1 | |
| SCHEMBL2592697 | 0.91 | ACHE (0.67) | ACHEEPHX1 | |
| SCHEMBL10939707 | 0.88 | ACHE (0.81) | ACHEEPHX2EPHX1 | |
| SCHEMBL7569673 | 0.88 | ACHE (0.81) | ACHEEPHX2EPHX1 | |
| SCHEMBL3975468 | 0.88 | ACHE (0.88) | ACHEEPHX2EPHX1 | |
| SCHEMBL31122612 | 0.88 | ACHE (0.74) | ACHEEPHX2EPHX1 | |
| SCHEMBL10447924 | 0.86 | ACHE (0.85) | ACHEEPHX2EPHX1 | |
| SCHEMBL7693489 | 0.86 | ACHE (0.78) | ACHEEPHX2EPHX1 | |
| SCHEMBL473236 | 0.86 | ACHE (0.85) | ACHEEPHX2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4536653-A2 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | Eisai R&D Management Co., Ltd. (JP) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023239906-A2 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2023-12-14 | — | — | WO | disclosed |
| EP-4161522-A1 | PYRAZOLO[4,3-D]PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CELLULAR PROLIFERATIVE DISORDERS | Merck Sharp & Dohme LLC (US) | 2023-04-12 | — | — | EP | disclosed |
| EP-4132583-A1 | PHTHALOCYANINE DYE COMPOUNDS, CONJUGATES AND METHODS OF USE THEREOF | Rakuten Medical, Inc. (US) | 2023-02-15 | — | — | EP | disclosed |
| WO-2021067458-A1 | PROTEIN-MACROMOLECULE CONJUGATES AND METHODS OF USE THEREOF | BEIJING XUANYI PHARMASCIENCES CO., LTD. (CN) | 2021-04-08 | — | — | WO | disclosed |
| EP-3233826-A1 | NEW ANTIBACTERIAL COMPOUNDS | Aziende Chimiche Riunite Angelini Francesco A.C.R. (IT) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016096631-A1 | NEW ANTIBACTERIAL COMPOUNDS | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2016-06-23 | — | — | WO | disclosed |
| EP-0997464-B1 | 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists | PFIZER (US) | 2005-02-16 | — | — | EP | disclosed |
| US-6465478-B1 | 1,3,8-Triuazaspiro(4,5)decanone compounds as ORL1-receptor agonists | PFIZER INC. | 2002-10-15 | — | — | US | disclosed |
| CN-1351602-A | Novel Pharmaceutically Active Compounds | ASTRAZENECA AB (SE) | 2002-05-29 | — | — | CN | disclosed |
| EP-1102762-A2 | 2-SUBSTITUTED-1-PIPERIDYL BENZIMIDAZOLE COMPOUNDS AS ORL1-RECEPTOR AGONISTS | PFIZER INC. (US) | 2001-05-30 | — | — | EP | disclosed |
| WO-2001022919-A2 | SPIRO[BICYCLIC -AZACYCLOALKYL AND -CYCLOALKYL] DERIVATIVES AND USES THEREOF | MERCK & CO., INC. (US) | 2001-04-05 | — | — | WO | disclosed |
| WO-2000029386-A1 | PYRIMIDINEDIONE DERIVATIVES USEFUL AS ALPHA 1A ADRENOCEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2000-05-25 | — | — | WO | disclosed |
| EP-0997464-A1 | 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists | PFIZER INC. (US) | 2000-05-03 | — | — | EP | disclosed |
| WO-2000008013-A2 | 2-SUBSTITUTED-1-PIPERIDYL BENZIMIDAZOLE COMPOUNDS AS ORL1-RECEPTOR AGONISTS | PFIZER PHARMACEUTICALS INC. (JP) | 2000-02-17 | — | — | WO | disclosed |